Evaluation of prognostic value of neutrophil-to-lymphocyte ratio in patients with acute-on-chronic liver failure or severe liver injury from chronic HBV infection, Jian Sun, Hongying Guo, Xueping Yu, Jingwen Chen, Haoxiang Zhu, Xun Qi, Xueyun Zhang, Jiajia Han, Xiaoqin Liu, Jianghua Yang, Jiefei Wang, Zhiping Qian, Yuxian Huang, Richeng Mao, Jiming Zhang, 2021
Viral quasispecies quantitative analysis: a novel approach for appraising the immune tolerant phase of chronic hepatitis B virus infection, Mingjie Wang, Li Chen, MinHui Dong, Jing Li, Beidi Zhu, Zhitao Yang, Qiming Gong, Yue Han, Demin Yu, Donghua Zhang, Fabien Zoulim, Jiming Zhang, Xinxin Zhang, 2021
A putative amphipathic alpha helix in hepatitis B virus small envelope protein plays a critical role in the morphogenesis of subviral particles, Sisi Yang, Zhongliang Shen, Yaoyue Kang, Liren Sun, Usha Viswanathan, Hongying Guo, Tianlun Zhou, Xinghong Dai, Jinhong Chang, Jiming Zhang, Ju-Tao Guo, 2021
Translatomic profiling reveals novel self-restricting virus-host interactions during HBV infection, Shilin Yuan, Guanghong Liao, Menghuan Zhang, Yuanfei Zhu, Kun Wang, Weidi Xiao, Caiwei Jia, Minhui Dong, Na Sun, Axel Walch, Ping Xu, Jiming Zhang, Qiang Deng, Ronggui Hu, 2021
Naturally occurring 5' preS1 deletions markedly enhance replication and infectivity of HBV genotype B and genotype C, Li J, Li J, Chen S, Yuan Q, Zhang J, Wu J, Jiang Q, Wang Q, Xia NS, Zhang J, Tong S, 2020
Characterization of IL-21-expressing recombinant hepatitis B virus (HBV) as a therapeutic agent targeting persisting HBV infection, Shen Z, Wu J, Gao Z, Wang J, Zhu H, Mao R, Wang X, Zhang J, Xie Y, Liu J, 2020
IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models, Shen Z, Liu J, Wu J, Zhu Y, Li G, Wang J, Luo M, Deng Q, Zhang J, Xie Y, 2019
Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection, Yang F, Yu X, Zhou C, Mao R, Zhu M, Zhu H, Ma Z, Mitra B, Zhao G, Huang Y, Guo H, Wang B, Zhang J, 2019
Naturally occurring core protein mutations compensate for the reduced replication fitness of a lamivudine-resistant HBV isolate, Zhang Y, Zhang H, Zhang J, Zhang J, Guo H, 2019
Hepatitis B Virus Precore Protein p22 Inhibits Alpha Interferon Signaling by Blocking STAT Nuclear Translocation, Mitra B, Wang J, Kim ES, Mao R, Dong M, Liu Y, Zhang J, Guo H, 2019
Serum hepatitis B virus RNA levels as a predictor of HBeAg seroconversion during treatment with peginterferon alfa-2a, Jia W, Zhu MQ, Qi X, Wang T, Wen X, Chen PD, Fan QQ, Zhang WH, Zhang JM, 2019
Exonuclease I and III improve the detection efficacy of hepatitis B virus covalently closed circular DNA, Jiang PX, Mao RC, Dong MH, Yu XP, Xun Q, Wang JY, Jing L, Qiang D, Zhang JM, 2018
Validation and comparison of seventeen noninvasive models for evaluating liver fibrosis in Chinese hepatitis B patients, Dong M, Wu J, Yu X, Li J, Yang S, Qi X, Mao R, Zhang Y, Yu J, Zhu H, Yang F, Qin Y, Zhang J, 2018
Differentially expressed intrahepatic genes contribute to control of hepatitis B virus replication in the inactive carrier phase, Liu H, Li F, Zhang X, Yu J, Wang J, Jia J, Yu X, Shen Z, Yuan Z, Zhang X, Zhang Z, Zhang X, Lu L, Li H, Lu M, Zhang J, 2018
Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase levels, Li J, Zhang TY, Song LW, Qi X, Yu XP, Li FH, Zhou P, Qin YL, Yang L, Zhao JH, Mao RC, Zhang YM, Wang JY, Yang FF, Zhu HX, Yang SS, Huang YX, Yuan Q, Zhang J, Zhang JM, Xia NS, 2018
Hepatitis B virus persistence in mice reveals IL-21 and IL-33 as regulators of viral clearance, Shen Z, Yang H, Yang S, Wang W, Cui X, Zhou X, Liu W, Pan S, Liu Y, Zhang J, Zhang J, Xie Y, Liu J, 2017
Area of Focus
Infectious Diseases | Diagnosis | Treatment | Pathogenesis | Research | Epidemiology | Virology | Immunology | Clinical Trials | Public Health
